Jointown Pharmaceutical Group Co., Ltd. Class ASSE: 600998

"Jointown Pharmaceutical Group Co., Ltd."Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2026

Sep 10, 2026 · Issued by Jointown Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Jointown Pharmaceutical Group Co., Ltd. Class A

"Jointown Pharmaceutical Group Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance BriefingSep 3
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 24th Meeting of the 6th Board of DirectorsSep 1
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Winning of a Bid by a Controlled Subsidiary for the County-level Medical Community Information Integration Construction ProjectAug 29
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance of the Second Tranche of Asset-backed Commercial Paper for 2026 (Supporting the Elderly Care Industry) and Related Party TransactionsAug 28

All Jointown Pharmaceutical Group Co., Ltd. Class A news releases